Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment ; volume:19 ; number:1 ; day:23 ; month:4 ; year:2021 ; pages:1-13 ; date:12.2021
Journal of translational medicine ; 19, Heft 1 (23.4.2021), 1-13, 12.2021
- Creator
-
Ntari, Lydia
Nikolaou, Christoforos
Kranidioti, Ksanthi
Papadopoulou, Dimitra
Christodoulou-Vafeiadou, Eleni
Chouvardas, Panagiotis
Meier, Florian
Geka, Christina
Denis, Maria C.
Karagianni, Niki
Kollias, George
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-021-02764-y
- URN
-
urn:nbn:de:101:1-2021061020230028684182
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ntari, Lydia
- Nikolaou, Christoforos
- Kranidioti, Ksanthi
- Papadopoulou, Dimitra
- Christodoulou-Vafeiadou, Eleni
- Chouvardas, Panagiotis
- Meier, Florian
- Geka, Christina
- Denis, Maria C.
- Karagianni, Niki
- Kollias, George
- SpringerLink (Online service)
Other Objects (12)
Monitoring of anti-TNF biological treatments
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Stopping Anti-TNF in CD Remitters: Cons
Anti-TNF, a magic bullet in cancer immunotherapy?
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Der molekulare Wirkmechanismus der anti-TNF Antikörper bei chronisch entzündlichen Darmerkrankungen
A review of ocular adverse events of biological anti-TNF drugs
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
Monitoring of anti-TNF biological treatments
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Stopping Anti-TNF in CD Remitters: Cons
Anti-TNF, a magic bullet in cancer immunotherapy?
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Der molekulare Wirkmechanismus der anti-TNF Antikörper bei chronisch entzündlichen Darmerkrankungen
A review of ocular adverse events of biological anti-TNF drugs
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
Monitoring of anti-TNF biological treatments
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Stopping Anti-TNF in CD Remitters: Cons
Anti-TNF, a magic bullet in cancer immunotherapy?
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Der molekulare Wirkmechanismus der anti-TNF Antikörper bei chronisch entzündlichen Darmerkrankungen
A review of ocular adverse events of biological anti-TNF drugs
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients